Garlic supplements can dangerously increase bleeding risk when taken with blood thinners like warfarin or apixaban. Learn why even natural supplements can be life-threatening and what steps to take to stay safe.
Learn how to talk to your doctor about generic vs. brand-name medications, why generics are just as effective, when to ask for brand-name drugs, and how to save money without risking your health.
Post-market surveillance catches dangerous side effects that clinical trials miss. Learn how real-world data from patients and doctors helps uncover hidden risks in drugs and medical devices after approval.
Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs under FDA regulations. Learn how bioequivalence testing, manufacturing controls, and strict approval processes ensure generics work just as well.
Medical societies have conflicting positions on generic drug substitution. While most support generics for cost savings, neurologists and others warn against switching NTI drugs like anticonvulsants due to safety risks. What providers really think - and what patients should know.
Psychiatric medication combinations can be life-changing, but switching to generic versions can trigger treatment failure, relapse, or hospitalization. Learn which drugs are safest to substitute-and which ones demand brand consistency.
Most clinicians don't know the real cost of the drugs they prescribe. This article explores why drug pricing knowledge is lacking, how it affects patient care, and what's being done to fix it-with real data and actionable insights.
Low-dose vitamin K supplements can help stabilize INR levels for people on warfarin by reducing daily fluctuations caused by inconsistent dietary intake. Learn how 150 mcg daily improves anticoagulation control without increasing bleeding risk.
Learn how to review and choose the best Medicare prescription drug plan each year to save money on medications. Avoid costly surprises with step-by-step guidance on formularies, pharmacy networks, and plan changes.
Natural disasters like hurricanes are causing life-threatening drug shortages by damaging key pharmaceutical manufacturing sites. With climate risks rising, the U.S. supply chain remains dangerously vulnerable-putting millions of patients at risk.
